EcoDrugPlus

Ensembl ID : ENSOJAG00000013875
Gene Symbol: -
Cross references: -
334 Possible Orthologues:

Ensembl ID : ENSOJAG00000014874
Gene Symbol: -
Cross references: -
98 Possible Orthologues:

Ensembl ID : ENSOJAG00000011213
Gene Symbol: -
Cross references: -
208 Possible Orthologues:

Ensembl ID : ENSOJAG00000012740
Gene Symbol: RARGB
1 Cross references
377 Possible Orthologues:

Ensembl ID : ENSOJAG00000001914
Gene Symbol: -
Cross references: -
185 Possible Orthologues:

Ensembl ID : ENSOJAG00000013897
Gene Symbol: -
Cross references: -
331 Possible Orthologues:

Ensembl ID : ENSOJAG00000013957
Gene Symbol: -
Cross references: -
331 Possible Orthologues:

Ensembl ID : ENSOJAG00000000583
Gene Symbol: -
Cross references: -
172 Possible Orthologues:

Ensembl ID : ENSOJAG00000018780
Gene Symbol: -
Cross references: -
193 Possible Orthologues:

Ensembl ID : ENSOJAG00000019292
Gene Symbol: -
Cross references: -
275 Possible Orthologues:

Ensembl ID : ENSOJAG00000014216
Gene Symbol: -
Cross references: -
115 Possible Orthologues:

Ensembl ID : ENSOJAG00000018348
Gene Symbol: -
Cross references: -
155 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).